D-0565-2022 Class II Terminated

Recalled by ANI Pharmaceuticals, Inc. — Baudette, MN

FDA drug recall D-0565-2022 was initiated by ANI Pharmaceuticals, Inc. on Feb 15, 2022 and is designated Class II. Reason for recall: cGMP Deviations The recall status is terminated (terminated Oct 25, 2022). Affected quantity: 205,662 bottles.

Recall details

Product Type
Drugs
Report Date
Feb 23, 2022
Initiation Date
Feb 15, 2022
Termination Date
Oct 25, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
205,662 bottles

Product description

Alprazolam Tablets, USP 0.5 mg, packaged in a) 100-count bottles (NDC 67253-901-10), b) 500-count bottles (NDC 67253-901-50), and c) 1000-count bottles (NDC 67253-901-11), Rx only, Distributed by: Par Pharmaceutical Chestnut Ridge, NY 10977

Reason for recall

cGMP Deviations

Distribution pattern

Nationwide within the United States

Code information

Lot #: a) 19B029A, Exp. Date 02/2022; 19D021A, Exp. Date 04/2022. b) 19A087B, 19A088B, 19A089B, 19A090B, Exp. Date 02/2022; 19A086B, 19A091B, 19B019B, Exp. Date 02/2022. c) 19B020C, 19B021C, 19B027C, 19B028C, Exp. Date 02/2022, 19E056C, 19E057C, Exp. Date 05/2022; 19E059C, Exp. Date 06/2022 19G072C, Exp. Date 07/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0565-2022
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0565-2022. Report a data issue: hello@regdatalab.com.